CME Group Gains 26% in a Year: Will the Rally Continue?
Shares of CME Group (CME) rally 26.1% in a year, backed by solid fundamentals and initiatives to ramp up growth.
Shares of CME Group (CME) rally 26.1% in a year, backed by solid fundamentals and initiatives to ramp up growth.
Shares of CME Group (CME) rally 26.1% in a year, backed by solid fundamentals and initiatives to ramp up growth.
Allstate's (ALL) diversified portfolio along with recent acquisitions position it for growth in 2019.
Allstate's (ALL) diversified portfolio along with recent acquisitions position it for growth in 2019.
Banking on top-line improvement, inorganic growth and strong liquidity, Marsh & McLennan (MMC) holds great potential to garner heavy returns for investors.
Banking on top-line improvement, inorganic growth and strong liquidity, Marsh & McLennan (MMC) holds great potential to garner heavy returns for investors.
Robust commission revenues, medicare application business and a probable expansion of enrollment volume help eHealth (EHTH) emerge as a prospective bet for yield-seeking investors.
Robust commission revenues, medicare application business and a probable expansion of enrollment volume help eHealth (EHTH) emerge as a prospective bet for yield-seeking investors.
Marsh & McLennan's (MMC) subsidiary introduces China desk in Dubai to benefit from the growing commercial links amid China, the Middle East and Africa.
Marsh & McLennan's (MMC) subsidiary introduces China desk in Dubai to benefit from the growing commercial links amid China, the Middle East and Africa.